The discovery of insulin in 1921 changed the prognosis for people with type 1 diabetes. A
century later, availability and affordability of insulin remain a challenge in many parts of the …

Methods Using payment data publicly disclosed by 92 major pharmaceutical companies, we
evaluated the financial relationships between pharmaceutical companies and …

Objectives Limited evidence is available regarding the financial relationships between
gastroenterologists and pharmaceutical companies in Japan. This study analysed the …

This cross‐sectional study evaluated the magnitude of personal payments made by
pharmaceutical companies to pediatric hematologist‐oncologists (PHOs) board‐certified by …

Rationale Pharmaceutical companies make payments to physicians such as compensations
for lecturing or consulting. Of particular, financial relationships between pharmaceutical …

Introduction: There are prevalent financial relationships between physicians and the
pharmaceutical industry in medical specialties, including otorhinolaryngology. Although …

Anju Murayama1,* Affiliations: 1 School of Medicine, Tohoku University, Sendai City, Miyagi,
Japan* Correspondence: Anju MurayamaTohoku University School of Medicine, 2-1 Seiryo …

Background Financial interactions between pharmaceutical companies and physicians lead
to conflicts of interest. This study examines the extent and trends of non-research payments …

Case reports involving two academic researchers suggest that adverse events (AEs) to
COVID-19 messenger RNA (mRNA) vaccination are largely underreported due to numerous …

Objective To evaluate the magnitude, prevalence, and trend of the financial relationship
between Japanese head and neck surgeons and pharmaceutical companies between 2016 …